Mirxes Faces Ongoing Trading Suspension as Auditors Probe Prepayments and Large Cash Outflows

Mirxes Holding Company Limited (HK:2629) is facing an ongoing trading suspension due to unresolved auditor concerns regarding significant prepayments and large cash outflows. KPMG has raised questions about the selection process for service providers and the reasonableness of contract terms. The company reported material cash outflows totaling approximately US$57 million and RMB10 million for investments and advisory fees. These issues are under review by an independent investigation committee, affecting Mirxes' governance and trading resumption conditions. The company focuses on expanding its laboratory testing and manufacturing capabilities in the life sciences sector.